lamotrigine

Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

A systematic review examines neurodevelopmental outcomes in children prenatally exposed to antiepileptic drugs.

By |2025-06-26T09:07:20-04:00May 1st, 2024|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

Essential Reads: Breastfeeding and Anti-Epileptic Drugs

While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.

By |2025-06-26T09:07:30-04:00August 10th, 2022|Anti-Epileptic Drugs, Breastfeeding & Medications, Essential Reads, Prevalence & Risk Factors|Comments Off on Essential Reads: Breastfeeding and Anti-Epileptic Drugs

Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)

These findings are encouraging and suggest that the newer AEDs, specifically lamotrigine and levetiracetam, are not associated with worse neurodevelopmental outcomes.

By |2025-06-26T09:06:51-04:00February 9th, 2022|Pregnancy & Medications|Comments Off on Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)

Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs

There is a growing body of literature to indicate that exposure to certain antiepileptic drugs, most notably valproic acid (VPA, Depakote) during critical periods of development may be associated with long-lasting neurodevelopmental deficits.

By |2025-06-26T09:07:34-04:00September 1st, 2021|Anti-Epileptic Drugs, Essential Reads, Neurodevelopmental Disorders, Pregnancy & Medications|Comments Off on Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs

Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy

Clinical Update 2020:  Lamotrigine (Lamictal) and Pregnancy Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly [...]

By |2025-06-26T09:06:58-04:00July 28th, 2020|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy

You Asked: Should Women Taking Lamotrigine (Lamictal) Use Higher Dose of Folic Acid When Planning for Pregnancy?

We have really enjoyed our weekly virtual rounds.  It’s been a great opportunity to meet other perinatal psychiatrists in the community, and discussions with new people always brings up interesting clinical questions.  Last week [...]

By |2025-06-26T09:06:59-04:00May 20th, 2020|Anti-Epileptic Drugs, Pregnancy & Medications, Treatment, You Asked|Comments Off on You Asked: Should Women Taking Lamotrigine (Lamictal) Use Higher Dose of Folic Acid When Planning for Pregnancy?

Lithium and Anticonvulsant Mood Stabilizers: No Higher Risk for Adverse Pregnancy Outcomes

For women with bipolar disorder, choosing whether to maintain or discontinue treatment with a mood stabilizer during pregnancy is challenging.  This is a process which requires careful and thoughtful consideration, weighing the risk of adverse [...]

By |2025-06-26T09:07:40-04:00August 5th, 2019|Pregnancy & Medications|Comments Off on Lithium and Anticonvulsant Mood Stabilizers: No Higher Risk for Adverse Pregnancy Outcomes
Go to Top